Although this has been observed in two distinct cancer models, the treatment of humanized GPVI mouse model with B16F10 skin tumor and blocking human GPVI function with Glenzocimab (ACT017) did not cause tumor bleeding (204). Here, GP6 is linked to skin neoplasm.